Anson Funds Management’s Genprex GNPX Stock Holding History

Anson Funds Management’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10	Closed	-$575K	–	383
2021 Q4	$575K	Buy	+10	New	+$834K	0.06%	218

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

Anson Funds Management's GNPX Position: Q1 2022 in Review

Anson Funds Management sold out of Genprex (GNPX) in Q1 2022, closing a stake of 10 shares — an estimated $575K sold.

Anson Funds Management first reported a position in GNPX in Q4 2021 and held it in 1 quarter. The position peaked at $575K in Q4 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q1 2022.

Anson Funds Management reported no remaining Genprex position as of Q1 2022 after selling out during the quarter.
Anson Funds Management sold 10 Genprex shares in Q1 2022, an estimated $575K.
Anson Funds Management first reported a position in Genprex in Q4 2021 and held it in 1 quarter.
Anson Funds Management's Genprex position peaked at $575K in Q4 2021.
20 funds tracked by Wall St. Rank held Genprex as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.